What one share of Cerus holds
We are a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on our proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.28 |
|---|---|
| Profit | −$0.03 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$0.01 |
| Cash and investments | $0.09 |
| Debt | $0.32 |
| Book value | $0.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $0.52 | −$0.69 | $0.01 | −$0.42 | — | $0.62 |
| 2010 | $0.57 | −$0.42 | $0.04 | −$0.40 | — | $0.30 |
| 2011 | $0.69 | −$0.35 | $0.00 | −$0.33 | — | $0.17 |
| 2012 | $0.67 | −$0.33 | $0.00 | −$0.25 | — | $0.34 |
| 2013 | $0.59 | −$0.64 | $0.01 | −$0.41 | — | $0.60 |
| 2014 | $0.48 | −$0.61 | $0.03 | −$0.55 | — | $0.52 |
| 2015 | $0.35 | −$0.61 | $0.01 | −$0.54 | — | $0.96 |
| 2016 | $0.39 | −$0.62 | $0.01 | −$0.53 | — | $0.56 |
| 2017 | $0.47 | −$0.56 | $0.00 | −$0.49 | — | $0.34 |
| 2018 | $0.58 | −$0.44 | $0.01 | −$0.25 | — | $0.62 |
| 2019 | $0.67 | −$0.51 | $0.06 | −$0.53 | — | $0.40 |
| 2020 | $0.70 | −$0.37 | $0.01 | −$0.26 | — | $0.62 |
| 2021 | $0.93 | −$0.32 | $0.01 | −$0.20 | — | $0.49 |
| 2022 | $1.07 | −$0.24 | $0.01 | −$0.16 | — | $0.38 |
| 2023 | $1.04 | −$0.21 | $0.03 | −$0.27 | — | $0.29 |
| 2024 | $1.09 | −$0.11 | $0.02 | $0.05 | — | $0.30 |
| 2025 | $1.23 | −$0.08 | $0.02 | $0.01 | — | $0.33 |
Common questions about Cerus
How much does one share of Cerus earn?
Over the last 12 months, Cerus lost $0.03 for each share on $1.28 of sales.
Does Cerus pay a dividend?
Cerus didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cerus’s book value per share?
Cerus’s book value is $0.35 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Cerus have?
Each share of Cerus has $0.09 of cash and investments and $0.32 of debt, as of June 30, 2026.
What is Cerus’s free cash flow per share?
−$0.01 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Cerus bought back shares?
Cerus’s share count rose about 448% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.